Connect with us

Technology

OmniScience’s clinical trial genAI-powered control tower, Vivo, wins 1st place in the CNS Summit 2024 Innovation Showcase

Published

on

OmniScience was awarded top honors at the 2024 Innovation Showcase for its groundbreaking solution, Vivo – a market-first solution poised to transform clinical trial operation teams’ day-to-day workflow and ability to optimize trial insights with genAI

HOUSTON, Nov. 26, 2024 /PRNewswire-PRWeb/ — The CNS Summit (Collaborating for Novel Solutions) was founded in 2010 by life sciences leaders devoted to discovering better, more efficient ways to advance the life sciences industry through innovation, collaboration, and technology.

Patients are waiting: The CNS Summit brings together life sciences leaders who aren’t afraid to challenge the status quo when it comes to the development of new treatments for patients

At the November 2024 CNS Summit in Boston, OmniScience was awarded top honors at the Innovation Showcase for its groundbreaking solution, Vivo – a market-first solution poised to transform clinical trial operation teams’ day-to-day workflow and ability to optimize trial insights with genAI.

CNS Summit Chairman and Chief Curator, Dr. Amir Kalali, stated, “At CNS Summit, we are proud to support leading startups. The CNS Summit Innovation Showcase is a competitive process with independent judging that showcases the top new startups in the life science ecosystem.”

“This award is a testament to the transformative impact of Vivo and the dedication of our team at OmniScience,” said Angela Holmes, CEO of OmniScience. “Winning the Innovation Showcase validates our vision of unifying clinical trial data to empower teams with real-time insights that drive faster, smarter decisions. We are honored to be recognized by our peers and remain committed to advancing clinical development for better patient outcomes in neurology and psychiatry and beyond.”

The CNS Summit Innovation Showcase is a stage for forward-thinking companies to share solutions that address pressing challenges in clinical development. This year’s submissions underwent a rigorous peer-review process, with Vivo being selected as one of the top four finalists based on its innovation, novelty, and potential impact on clinical research. Judges of the summit ultimately awarded Vivo the top position, recognizing its ability to streamline data accessibility and support actionable insights that reduce clinical trial timelines and increase probability of success. Notable organizations in attendance at the 2024 Summit included AbbVie, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Johnson & Johnson, Novo Nordisk, Pfizer, Roche, and Takeda.

Driving Efficiency in Complex Trials and Addressing the Challenges of Siloed Data in Clinical Trials:

“Clinical trial complexity is skyrocketing, especially in CNS trials, where we’re dealing with diverse data types from labs, sensors, digital biomarkers, and imaging,” said Michael Bell, PhD, VP of Product at OmniScience, who led the showcase presentation. “Vivo changes the game for biopharma teams, enabling them to access on-demand insights, detect data discrepancies, forecast enrollment timelines, and monitor site, safety, and clinical metrics—all in one unified portal. Our team at OmniScience has drawn on years of experience in clinical data science to bring Vivo to life, and this win reinforces our commitment to accelerating therapeutic development.”

Vivo was developed to address the significant hurdles clinical operations teams face in managing siloed data, which impede timely, informed decision-making. During his presentation, Dr. Bell demonstrated how Vivo’s genAI capabilities allow teams to ask complex questions—such as identifying operational and safety risks and monitoring data quality and completeness—and receive instant, plain-language answers. Vivo’s AI-driven approach enables the delivery of proactive notifications, helping teams make informed adjustments throughout their trials.

Designed with explainability and interpretability at its core, Vivo ensures that every generated insight is supported by clear, traceable rationale grounded in data and clinical context. Its advanced cognitive architecture combines ontological knowledge of trial protocols with domain-specific clinical expertise, enabling qualitative and quantitative reasoning at scale.

“We are proud to be recognized by our peers for Vivo’s potential to transform how biopharma approaches clinical trial data,” Bell shared. “OmniScience has built a product that empowers study teams and their CROs with the oversight and insights they need to get critical treatments to patients faster.”

About the CNS Summit Innovation Showcase:

The CNS Summit Innovation Showcase is an annual opportunity for emerging companies to spotlight their innovative solutions in clinical research. This event brings together technology companies and industry leaders, creating a collaborative environment where groundbreaking ideas meet strategic partners. Through peer review, attendee voting, and independent judging, the showcase rewards innovation that has the potential to accelerate the development of life-changing therapies.

About OmniScience:

OmniScience is a trusted partner to leading life science organizations advancing clinical R&D missions through unparalleled expertise in clinical data science. Our expert team has served biopharma as a data science CRO, developing AI/ML solutions to translate complex clinical trial data into insights.

We believe in a future where all clinical trial data can be unified and translated into knowledge in real time. That’s why we created Vivo – your new favorite clinical development colleague.

Improve monitoring and oversight. Make better decisions with higher quality data. Reduce cost. Shorten timelines. If you would like to discuss how we can support your clinical trials, reach us at hello@omniscience.bio or on LinkedIn.

Media Contact
Carla Holloway, OmniScience, 1 3023790441, carla.holloway@omniscience.bio, omniscience.bio

View original content to download multimedia:https://www.prweb.com/releases/omnisciences-clinical-trial-genai-powered-control-tower-vivo-wins-1st-place-in-the-cns-summit-2024-innovation-showcase-302316131.html

SOURCE OmniScience

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

FULTON FINANCIAL CORPORATION APPOINTS DAVID S. SCHULZ TO BOARD OF DIRECTORS

Published

on

By

LANCASTER, Pa., July 21, 2026 /PRNewswire/ — Fulton Financial Corporation (NASDAQ: FULT) (“Fulton”) today announced the appointment of David S. Schulz as a member of its board of directors (the “Board”) for a term commencing September 14, 2026 and expiring at Fulton’s 2027 annual meeting of shareholders.

“We’re excited to welcome Dave to Fulton’s board of directors,” said Curt Myers, Fulton Chairman, CEO, and President. “Dave brings extensive financial leadership experience gained through more than a decade of service with publicly traded companies. His expertise in finance, strategic planning, risk, and mergers and acquisitions will provide valuable perspective as we continue to execute our growth strategy and create long-term value for our shareholders, customers and communities.”

With the addition of Schulz, Fulton’s Board will have 11 members, and he will serve on the Audit and Risk committees. Schulz has also been appointed to the board of directors of Fulton’s banking subsidiary, Fulton Bank, N.A.

Schulz served as Senior Vice President and Chief Financial Officer of Wesco International, Inc. (“Wesco”) from 2016 to June 2020, Executive Vice President and Chief Financial Officer of Wesco from June 2020 to February 2026 and as Executive Vice President and Special Advisor to the CEO of Wesco from February 2026 until his retirement on May 31, 2026. 

Prior to joining Wesco, Schulz served as Senior Vice President and Chief Operating Officer of Armstrong Flooring, Inc. and was previously Senior Vice President and Chief Financial Officer of Armstrong World Industries, Inc. and Vice President of Finance of the Armstrong Building Products division.

Before joining Armstrong World Industries in 2011, he held various financial leadership roles with Procter & Gamble and The J.M. Smucker Company. He was also an officer in the United States Marine Corps.

In 2025, Schulz joined the board of Sterling Infrastructure, Inc., and he was appointed as chair of the audit committee in 2026. He also serves on the company’s compensation and talent development committee.

ABOUT FULTON FINANCIAL CORPORATION

Fulton, a $34 billion Lancaster, Pa.-based financial holding company, has more than 3,400 employees and operates more than 215 financial centers in Pennsylvania, New Jersey, Maryland, Delaware and Virginia through Fulton Bank, N.A. Additional information on Fulton can be found at https://investor.fultonbank.com.

Contact: Steve Trapnell
717-291-2739

View original content to download multimedia:https://www.prnewswire.com/news-releases/fulton-financial-corporation-appoints-david-s-schulz-to-board-of-directors-302831288.html

SOURCE Fulton Financial Corporation

Continue Reading

Technology

Octavio Marquez Elected to MSA Safety Board of Directors

Published

on

By

PITTSBURGH, July 21, 2026 /PRNewswire/ — The Board of Directors of MSA Safety Inc. (NYSE: MSA), a global leader in the development of advanced industrial safety technology products and solutions, today announced that Octavio Marquez, president and chief executive officer of Diebold Nixdorf, has been elected to the company’s Board of Directors. His election was part of the MSA Board’s regular succession plans.

“We are very pleased to have the opportunity to add Octavio to the MSA Board,” said Robert A. Bruggeworth, MSA chairman. “He brings a broad range of executive leadership experience, including strategy development, capital allocation, business transformation and serving international markets, which will serve MSA well.”

“Octavio’s perspectives will be an asset to me and our entire Executive Leadership Team,” said Steven C. Blanco, MSA president and CEO. “It is a pleasure to welcome Octavio to MSA, and I look forward to working with him.”

Mr. Marquez joined Diebold Nixdorf in 2014 and has held senior leadership roles across the company’s Global Banking organization and its Americas region, including as executive vice president of Global Banking and senior vice president of the Americas. Before joining Diebold Nixdorf, Mr. Marquez held leadership positions at Dell EMC, Hewlett Packard Enterprise, IBM and NCR.

Diebold Nixdorf automates, digitizes and transforms the way people bank and shop. As a partner to the majority of the world’s top 100 financial institutions and top 25 global retailers, its integrated solutions connect digital and physical channels conveniently, securely and efficiently for millions of customers every day. Headquartered in North Canton, Ohio, Diebold Nixdorf employs approximately 20,000 employees globally, supporting more than 100 countries.

Mr. Marquez holds a degree in business and finance from Universidad Iberoamericana and has completed executive education programs at MIT Sloan, The Wharton School and The University of Texas at Austin.

About MSA Safety

MSA Safety Incorporated (NYSE: MSA) is the global leader in advanced industrial safety technology products and solutions. Driven by its singular mission of safety, the company has been at the forefront of safety innovation since 1914, protecting workers and facility infrastructure around the world across a broad range of diverse end markets while creating sustainable value for shareholders. With 2025 revenues of $1.9 billion, MSA Safety is headquartered in Cranberry Township, Pennsylvania, and employs a team of approximately 5,300 associates across its more than 40 international locations. For more information, please visit www.MSASafety.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/octavio-marquez-elected-to-msa-safety-board-of-directors-302831265.html

SOURCE MSA Safety

Continue Reading

Technology

BlueFolder Field Service Software Launches New AI-Powered Features to Transform How Teams Work

Published

on

By

New AI capabilities instantly surface customer insights and transform technician notes into actionable summaries to help field service teams work faster, stay aligned, and deliver better service

AUBURN, Ala., July 21, 2026 /PRNewswire/ — BlueFolder field service software recently announced the launch of two powerful new AI features: AI-Powered Customer Summaries and AI-Powered Field Notes Summarization. Together, these capabilities are designed to eliminate the time-consuming, manual work of reviewing fragmented customer records and lengthy technician notes—giving field service teams instant clarity to respond faster, make smarter decisions, and deliver exceptional service.

BlueFolder expands it’s field service and work order management suite with two exciting new AI field service features.

Built directly into the BlueFolder platform, both features leverage artificial intelligence to automatically compile and summarize complex, unstructured data into clear, easy-to-read overviews. The result: technicians, dispatchers, and managers always have the context they need, right when they need it.

AI-Powered Customer Summaries

As field service organizations grow, customer information becomes increasingly scattered across emails, service request logs, and communication histories. BlueFolder’s AI Customer Summary feature addresses this challenge head-on by consolidating those interactions into a single, actionable snapshot.

Instead of manually digging through multiple records before a service call or customer interaction, teams can now access a real-time summary highlighting key concerns, past service activity, and recent updates. The feature goes beyond basic summarization and surfaces critical business insights such as equipment past due for maintenance, approaching warranty expirations, and proactive revenue opportunities, empowering teams to recommend follow-ups or upgrades directly from the customer record.

Built-in traceability links each summary back to its original source communications, so users can validate insights with confidence, ensuring both speed and accuracy in every customer interaction.

AI-Powered Field Notes Summarization

In many service organizations, technicians log updates across multiple visits, often resulting in long, fragmented notes that are difficult to review at a glance. BlueFolder’s AI Field Notes Summarization feature solves this by automatically condensing multiple technician entries into a structured summary that highlights key milestones, actions taken, and next steps.

Rather than scrolling through pages of updates, managers and dispatchers can immediately understand job status and determine what needs to happen next, improving alignment between field and office teams, accelerating decision-making, and reducing miscommunication. The feature is especially valuable for complex or multi-day jobs, where clear continuity and smooth technician handoffs are critical to delivering consistent service. It’s another featuring making BlueFolder’s work order management software capabilities stronger every day.

“History is one of the most powerful tools a service team has — the problem is it’s usually buried. BlueFolder’s new AI features fix that. Your team walks into every interaction already knowing the customer, knowing the equipment, and exactly where things stand. That changes the entire experience,” says John Shaw, VP, Technology, Service Operations.

AI as a Core Part of the BlueFolder Platform

The launch of these two features reflects BlueFolder’s broader commitment to embedding AI throughout its field service management software as an integrated layer of intelligence that makes every workflow smarter. Rather than requiring teams to change how they work, BlueFolder’s AI capabilities are designed to surface the right information at the right moment automatically, within the tools that technicians, dispatchers, and managers already use every day.

“AI is transforming what’s possible in field service, and BlueFolder is answering that call. These features are the result of deep platform expertise and a clear vision for where the industry is headed. We’re embedding intelligence throughout the platform because we know it makes our customers more competitive, more efficient, and better positioned to grow,” says Stephen Myslicki, Group President of Field Services.

Availability

Both AI-Powered Customer Summaries and AI-Powered Field Notes Summarization are available now to BlueFolder customers as optional, easy-to-enable features within the platform. They are part of BlueFolder’s growing suite of AI-driven capabilities designed to help field service organizations operate more efficiently and scale with confidence.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bluefolder-field-service-software-launches-new-ai-powered-features-to-transform-how-teams-work-302831320.html

SOURCE BlueFolder

Continue Reading

Trending